From developing life-saving medicines to enhancing the oil content of crops for better cardiovascular health, biotech combines biology and technology to enhance people’s lives. While these companies have made significant progress, they are still just scratching the surface and are expanding their teams in Irish cities like Dublin to amplify their impact. Here are a few companies to follow.
Biotech Companies in Dublin
- Pfizer
- Prothena Corporation
- ICON
- Micron Agritech
- Nuritas
Biotech Companies in Dublin to Know
Nuritas aims to empower consumers to live healthier lives by making the everyday products they consume safer, healthier and greener. The company uses artificial intelligence to identify peptides in plants and natural food sources that can enhance health by serving as ingredients for food and beverage products, skincare and more.
Micron Agritech leverages digital technology to test animals for parasites. With its app, users can take a video of a sample, upload it to an analysis server, and receive rapid, accurate results processed by artificial intelligence, delivered directly to their device. In doing so, it reduces costs and environmental impact.
ICON is a healthcare intelligence and clinical research organization with a team of over 8,000 dedicated exclusively to serving the needs of small and medium-sized biopharma companies. The company has the world’s largest dedicated biotech division and supports more than 500 biotech sponsors each year.
The genealogy company Ancestry is known for turning genetic science processes into a consumer products. Through its in-home DNA testing and analysis kits, the company is able to provide users with comprehensive DNA analysis that includes DNA matches and ancestral origins, using SNP-genotyping technology. Within the home-DNA testing industry, Ancestry boasts the largest database of DNA matches, making it desirable for users who are seeking far flung relatives in their family trees.
The biotech company Amgen makes therapeutics for human healthcare. Its products are divided across oncology, inflammation treatments, rare diseases and general medicine. The company is invested in deep tech applications that use AI and generative biology in the drug discovery and device development pipelines.
Founded in 1948, Pfizer is one of the world’s largest research-based pharmaceutical and biomedical companies, specializing in developing and manufacturing medications and vaccines for both humans and animals. Some of its products include Zoloft, Viagra and Xanax, as well as the COVID-19 vaccine.
Prothena Corporation is a late-stage clinical biotechnology company headquartered in Dublin, focusing on protein disregulation and developing a diverse pipeline of innovative therapies for neurodegenerative and rare peripheral amyloid diseases, which affect millions of people worldwide. The company also has an office in New York City.
Viatris is a global healthcare firm. In Ireland it is a leading provider of biotechnology and pharmaceutical products and services. The company’s offerings focus on branded and generic pharmaceutical products, which include the category-defining medications Viagra, Xanax and Lipitor. Viatris’ biotechnology research and development is tuned toward biosimilars, which are medications made to closely mimic biologic drugs.
Eli Lilly and Company is a multinational enterprise healthcare company with operations in the pharmaceutical and biotechnology verticals. The company is noted for achieving the highest valuation in its industry at a $842 billion USD market capitalization, which has been possible in large part due to the success of products such as Cymbalta and the legacy SSRI Prozac. Lilly’s biotech initiatives include the establishment of a dedicated biotechnology research and manufacturing complex.
Biotech company Regeneron researches, develops and manufactures treatments for rare and chronic conditions and diseases. As much of the pharmaceutical and biotech industry turns to third-party contract research organizations to conduct their processes, Regeneron insists on keeping all its R&D in house. The company is currently in developmental stages on cell medicine, genetic medicine and biologic products, with potential applications in hematology, ophthalmology and neurology.
